Skip to content

MAXILLO MED

Active
Private limited companyfounded 20251 yr activeRue des Marronniers 146, 7380 Quiévrain, BelgiumKBO/BCE: BE 1019.366.565
Summary

The computed 12-month bankruptcy probability of MAXILLO MED is 1.9% (moderate). The 2025 annual accounts show equity of €34,466 and a net result of €9,466. The company has been active since 2025 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2025
Axes
Profitability78
Solvency51
Growth-
Track record67
Bankruptcy probability, 12 months
1.9% Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €2,000 at 30 days acceptable
Liquidity tight (current ratio 1.07; short-term debt: 37.5% and cash: 18.9% of total assets), and 74% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 1 year 0 10 y
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
26%
Return on assets
7.1%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 04-09-2026, 35 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 1 filing
Deviation from the deadline
2025
35 d late
← before the deadline after the deadline →
Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 29 January 2025, MAXILLO MED was incorporated as a Private limited company.1 The company has filed annual accounts once, for fiscal year 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
€34,466
Total assets
€132,400
Net result
€9,466
Working capital
€3,466

Turnover and EBIT margin not published: the micro schema does not require them.

Balance-sheet composition
Assets €130,968
Fixed assets €77,914
Current assets €53,054
Equity and liabilities €132,400
Equity €34,466
Debt €97,934
Debt finances 74.0% of the balance-sheet total.
Key figures and ratios
2025 value
EBITDA
€18,684
Cash flow
€14,801
Current ratio
1.07
Debt to equity
2.84
ROE
27.5%
ROA
7.1%
Interest coverage
66.45
Debt ≤ 1 year
€49,588
Debt > 1 year
€48,346
Income taxes
€3,602

Peer companies

Historical observation

Of the 2,390 companies that looked in July 2024 the way this one looks now, 1.2% went bankrupt within 24 months and 97% are still going.

  • Micro
  • under 2 years old
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more
1.2% went bankrupt
2.0% stopped otherwise
97% still going

A further 0.2% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a higher bankruptcy probability: 1.9% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,338 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.9%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 2,390 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 · 33 lines
Balance sheet Code2025
Assets
Total assets20/58€132,400
Formation expenses20€1,432
Fixed assets21/28€77,914
Tangible fixed assets22/27€77,914
Furniture and vehicles24€77,914
Current assets29/58€53,054
Cash at bank and in hand54/58€25,086
Deferred charges and accrued income490/1€27,967
Equity and liabilities
Total equity and liabilities10/49€132,400
Equity10/15€34,466
Contributions10/11€25,000
Profit (loss) carried forward14€9,466
Amounts payable17/49€97,934
Amounts payable after more than one year17€48,346
Financial debts170/4€48,346
Amounts payable within one year42/48€49,588
Current portion of amounts payable after more than one year42€15,397
Trade debts44€21,941
Suppliers440/4€21,941
Taxes, remuneration and social security45€12,250
Taxes450/3€3,602
Remuneration and social security454/9€8,649
Income statement Code2025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€5,334
Other operating charges640/8€493
Gross operating margin9900€19,177
Operating profit (loss)9901€13,349
Financial charges65/66B€281
Recurring financial charges65€281
Profit (loss) for the period before taxes9903€13,068
Income taxes67/77€3,602
Profit (loss) for the period9904€9,466
Profit (loss) for the period to be appropriated9905€9,466
Appropriation of the result
Profit (loss) to be appropriated9906€9,466

The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€5,334
Other operating charges640/8€493
Gross operating margin9900€19,177
Operating profit (loss)9901€13,349
Financial charges65/66B€281
Recurring financial charges65€281
Profit (loss) for the period before taxes9903€13,068
Income taxes67/77€3,602
Profit (loss) for the period9904€9,466
Profit (loss) for the period to be appropriated9905€9,466
Line2025
Assets
Total assets20/58€132,400
Formation expenses20€1,432
Fixed assets21/28€77,914
Tangible fixed assets22/27€77,914
Furniture and vehicles24€77,914
Current assets29/58€53,054
Cash at bank and in hand54/58€25,086
Deferred charges and accrued income490/1€27,967
Equity and liabilities
Total equity and liabilities10/49€132,400
Equity10/15€34,466
Contributions10/11€25,000
Profit (loss) carried forward14€9,466
Amounts payable17/49€97,934
Amounts payable after more than one year17€48,346
Financial debts170/4€48,346
Amounts payable within one year42/48€49,588
Current portion of amounts payable after more than one year42€15,397
Trade debts44€21,941
Suppliers440/4€21,941
Taxes, remuneration and social security45€12,250
Taxes450/3€3,602
Remuneration and social security454/9€8,649
Line2025
Profit (loss) for the period9904€9,466
+ Depreciation and write-downs630€5,334
Operating cash flow (approximation)€14,801

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2026
04-09
NBB filing Annual accounts filed
fiscal year 2025 · micro schema · 35 days late
NBB filing
0 of 1 act read
About the unread acts

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Quiévrain · 1 establishment unit since 2025
seat establishment The establishment unit on the map
Ground area
396 m²
Building footprint
81 m²
Volume, LiDAR
504 m³
Parcel 53008A0501/00G000, Wallonia · tallest building 8.1 m, ±2 floors. Linked by address, not a title deed.
2 companies at this address See who is registered here
1 establishment unit
MAXXILLO MED
Rue des Marronniers 146, 7380 QuiévrainSpecialist medical practice
since 20252.369.267.857
1 parcel
Wallonia 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
53008A0501/00G000 Wallonia 396 m² 1 · 81 m² 8.1 m · 2 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Identification & contact

Identification
Legal formPrivate limited company
Founded29-01-2025
Fiscal year end31-12
Contact
E-mail secretariat@maxillomed.be
E-invoicing
Reachable via Peppol
Peppol ID 0208:1019366565
Also 9925:BE1019366565
Registered 19-12-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 28 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.